Related Experiment Video
Updated: Aug 1, 2025
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
28.5K
Combing fecal microbial community data to identify consistent obesity-specific microbial signatures and shared
Yu Lin1,2,3, Zhilu Xu1,2,3, Yun Kit Yeoh1,2,4
1Microbiota I-Center (MagIC), Hong Kong SAR, China.
Iscience
|April 25, 2023
Summary
Obesity is linked to an altered gut microbiome, with key beneficial bacteria depleted. This study identified specific microbial signatures and pathways that could help mitigate obesity and related metabolic diseases.
Area of Science:
- Microbiology
- Metabolic Diseases
- Gut Microbiome Research
Background:
- Obesity is linked to changes in gut microbiome composition, but findings vary across populations.
- Understanding these variations is crucial for developing targeted interventions.
Purpose of the Study:
- To meta-analyze 16S rRNA gene sequencing data from 18 studies to identify obesity-associated gut microbiome alterations.
- To investigate the functional pathways and predictive potential of these microbial signatures in obesity.
Main Methods:
- Meta-analysis of 18 publicly available 16S rRNA gene sequencing datasets.
- Differential abundance analysis of microbial taxa and functional pathways.
- Machine learning models for obesity prediction using microbiome data.
Main Results:
- Several genera, including *Odoribacter*, *Oscillospira*, *Akkermansia*, *Alistipes*, and *Bacteroides*, were found to be depleted in obese individuals.
- Functional pathways indicated metabolic adaptation to specific dietary patterns (high-fat, low-carbohydrate, low-protein).
- Machine learning models showed modest obesity prediction (AUC 0.608), improving significantly (AUC 0.771) with studies focused on obesity-microbiome links.
Conclusions:
- The obese gut microbiome is characterized by a deficiency in certain commensal microbes.
- Identified microbial signatures and functional pathways offer potential targets for mitigating obesity and associated metabolic disorders.
